Insights on Discovery

1. Accelerating Cell Therapy Discovery With High-Throughput Electroporation 7/31/2026

   Discover how high-throughput electroporation-based screening can compress your CAR-T optimization timeline while delivering reproducible, scale-ready results across multiple donor samples.

2. Addressing Gaps In The CGT Market Through Partnership 7/27/2026

   Reducing variability is critical to advancing cell therapy development. Learn how cell sourcing, quality-focused manufacturing strategies, and ecosystem partnerships can support reproducible research.

3. How Isogenic Organ-Chips Are Transforming The Future Of Research 6/25/2026

   Modeling the human brain requires more than simplified systems. New approaches that incorporate diverse cell types are improving how researchers study neurovascular function with greater precision.

4. A Timeline Of U.S. Actions To Reduce Animal Models In Research 6/25/2026

   Policy and scientific validation have aligned to shift drug development beyond animal models. New regulations and technologies are making human‑relevant methods the standard for preclinical research.

5. mRNA LNPs Drive Safe, Effective Repeat Dosing In Disease Models 6/19/2026

   Well-designed lipid nanoparticles enable safe, efficient delivery. OVA-based models show how formulation choices shape efficacy, safety, and anti-tumor outcomes in melanoma research.

6. CRISPR Reagents Enable High Efficiencies Of Editing And HDR In iPSCs 6/15/2026

   Achieving consistent Homology Directed Repair (HDR) in iPSCs requires optimized CRISPR design and workflows. See how advanced reagents and targeted enhancement strategies improve insertion efficiency.

7. CAR Detection Reagents - Applications For Flow Cytometry 6/11/2026

   Precise detection of CAR T cells supports reliable analysis and imaging across workflows. See how flexible reagent strategies reduce background, improve specificity, and enable deeper insight.

8. Closing The QC Gap For mAbs: Rapid Answers Without Compromising 6/9/2026

   Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.

9. Designing RNase H1 "Gapmer" Antisense Oligonucleotides 6/9/2026

   Effective RNA-targeting oligonucleotide design hinges on balancing affinity, stability, and selectivity. Explore how chemical modifications, sequence choices, and delivery approaches influence potency.

10. T Cells In Immunotherapies: The Key Progress Underway 6/1/2026

    CAR-T therapies now make up 73% of active pipeline programs, yet solid tumors remain largely out of reach. Where is T cell immunotherapy headed next, and what does it mean for your pipeline strategy?